Head & Neck cancer

Worldwide, head and neck carcinomas account for 5% of all malignancies. Unfortunately, two-thirds of patients relapse after initial multimodal therapy. Until early 2010, the median overall survival (OS) of metastatic patients was approximately 10 months.
Peyrade et al. 2021 Current Opinion in Oncology 33(3): 160-167

Head and neck cancer is the seventh most common type of cancer worldwide, comprising a diverse group of tumors that affect the upper aerodigestive tract. Although many different histologies exist, the most common type is Head & Neck squamous cell carcinoma (HNSCC)
Mody et al. 2021 Lancet 398: 2289-2299

Head and neck cancer includes tumors that develop in the:

• Mouth


• Throat


• Nose


• Salivary glands


• Oral regions


• Other area…